Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104548
Filing Date
2025-08-07
Accepted
2025-08-07 07:05:23
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q phat-20250630.htm   iXBRL 10-Q 2204794
2 EX-10.1 phat-ex10_1.htm EX-10.1 536790
3 EX-10.2 phat-ex10_2.htm EX-10.2 418572
4 EX-10.3 phat-ex10_3.htm EX-10.3 261225
5 EX-31.1 phat-ex31_1.htm EX-31.1 15581
6 EX-31.2 phat-ex31_2.htm EX-31.2 15636
7 EX-32.1 phat-ex32_1.htm EX-32.1 9633
8 EX-32.2 phat-ex32_2.htm EX-32.2 9660
9 GRAPHIC img230957851_0.jpg GRAPHIC 12002
  Complete submission text file 0000950170-25-104548.txt   10675064

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT phat-20250630.xsd EX-101.SCH 1615094
69 EXTRACTED XBRL INSTANCE DOCUMENT phat-20250630_htm.xml XML 1449004
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 251191535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)